Delivery Order SPE2DB24D1021-SPE2DB25FEZHK
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $10,784.34 with a completion date of February 4, 2025. It is for the supply of Talzenna 0.5 mg Capsule 30s, a pharmaceutical product. This contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 0.25 mg softgel capsules of the drug Talzenna, with a ceiling value of $11,135.25 and a completion date of June 11, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,424.08 firm fixed-price delivery order is for the supply of Talzenna 0.5 mg capsules. The contract has an ultimate completion date of November 27, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,246.91, is a delivery order for the supply of a specific pharmaceutical product, Talzenna 0.5 mg softgel 30s. The contract is a firm fixed-price, non-set-aside arrangement with a completion date of May 8, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,135.25 firm-fixed-price contract is for the delivery of TALZENNA 0.35 MG SOFTGEL 30S, a pharmaceutical product. The contract has an ultimate completion date of June 3, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The $10,463.55 contract is for the delivery of TALZENNA 0.25 MG CAPSULE 30S, a specialty pharmaceutical product, to be performed at Amerisourcebergen's facility in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp also holds an indefinite delivery contract...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $11,135.25 firm fixed-price delivery order is for the supply of TALZENNA 0.35 MG SOFTGEL 30S, a pharmaceutical product. The contract has an ultimate completion date of August 1, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not set-aside. The company holds a significant Indefinite...
- This federal contract award, with ID SPE2DB20D1051|SPE2DB24FD7YN, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $20,848.16 Firm Fixed Price Delivery Order is for the supply of the pharmaceutical product Talzenna 0.5 mg capsules. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025. Under this single-award...
- This is a federal contract award made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TALZENNA 0.35 MG SOFTGEL 30S, a pharmaceutical product, with a ceiling value of $12,235.91 and a period of performance through May 2, 2025. This is a delivery order contract with a firm fixed price pricing type. The contract is not designated as a set-aside....
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,493.82, is for the delivery of TALZENNA 0.5 MG SOFTGEL 30S, a pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of April 30, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FEZHKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $11,135.25 to AmerisourceBergen Drug Corp for Talzenna 0.35 mg softgel capsules (30-count) with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger pharmaceutical supply contract vehicle with DLA. This delivery order is a child contract under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, regularly fulfills federal medical procurement requirements through open competition, supplying brand-name and generic medications, vaccines, and specialized healthcare commodities across multiple therapeutic domains to support Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.1k | 8/5/25 |